Cargando…

Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases

A total of 151 patients (age: 24–74 years, mean: 55 ± 10.3) diagnosed with Peyronie's disease were enrolled in a non-surgical treatment. In addition to medical histories and physical examinations, all patients underwent the following tests: penile ultrasound, IIEF questionnaire and photographic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paulis, G, D'Ascenzo, R, Nupieri, P, De Giorgio, G, Orsolini, G, Brancato, T, Alvaro, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437487/ https://www.ncbi.nlm.nih.gov/pubmed/21950543 http://dx.doi.org/10.1111/j.1365-2605.2011.01219.x

Ejemplares similares

Evaluation of Verapamil Efficacy in Peyronie’S Disease Comparing With Pentoxifylline
por: Alizadeh, M., et al.
Publicado: (2014)

Role of Oxidative Stress in Peyronie’s Disease: Biochemical Evidence and Experiences of Treatment with Antioxidants
por: Paulis, Gianni, et al.
Publicado: (2022)

Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease
por: Kokab, Abas, et al.
Publicado: (2014)

Disappearance of Plaque Following Treatment with Antioxidants in Peyronie’s Disease Patients—A Report of 3 Cases
por: Paulis, Gianni, et al.
Publicado: (2022)

Full Regression of Peyronie’s Disease Plaque Following Combined Antioxidant Treatment: A Three-Case Report
por: Paulis, Gianni, et al.
Publicado: (2022)

Complete Plaque Regression in Patients with Peyronie’s Disease After Multimodal Treatment with Antioxidants: A Report of 2 Cases
por: Paulis, Gianni, et al.
Publicado: (2022)

Patients with Peyronie’s disease achieve complete plaque regression after multimodal treatment with antioxidants: a case series
por: Paulis, Gianni, et al.
Publicado: (2022)

Rationale of combination therapy with antioxidants in medical management of Peyronie’s disease: results of clinical application
por: Paulis, Gianni, et al.
Publicado: (2017)

Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease
por: Dell’Atti, Lucio
Publicado: (2015)

Recent Pathophysiological Aspects of Peyronie's Disease: Role of Free Radicals, Rationale, and Therapeutic Implications for Antioxidant Treatment—Literature Review
por: Paulis, Gianni, et al.
Publicado: (2017)

Clinical and epidemiological characteristics of young patients with Peyronie’s disease: a retrospective study
por: Paulis, Gianni, et al.
Publicado: (2015)

A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study
por: Toscano, I. L., et al.
Publicado: (2016)

Peyronie’s disease after urethral swab, an unusual complication: a case report
por: Paulis, Gianni, et al.
Publicado: (2015)

Comparison of Intralesional Hyaluronic Acid vs. Verapamil for the Treatment of Acute Phase Peyronie's Disease: A Prospective, Open-Label Non-Randomized Clinical Study
por: Cocci, Andrea, et al.
Publicado: (2021)

Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: a case-control study
por: Paulis, Gianni, et al.
Publicado: (2015)

Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie’s disease: a retrospective analysis of 309 cases
por: Paulis, Gianni, et al.
Publicado: (2016)

Comparison of Blueberry (Vaccinium spp.) and Vitamin C via Antioxidative and Epigenetic Effects in Human
por: Kim, Minju, et al.
Publicado: (2017)

Verapamil in Diabetes
por: Poudel, Resham Raj, et al.
Publicado: (2017)

Proton radioactivity of $^{151}$Lu
por: Hofmann, S, et al.
Publicado: (1981)

Current state of affairs of Peyronie’s disease
por: Hellstrom, Wayne J. G., et al.
Publicado: (2016)

Verapamil: what is the mechanism of its anticarcinogenic activity?
por: Brambilla, G.
Publicado: (1994)

The pathophysiology of Peyronie’s disease
por: El-Sakka, Ahmed I., et al.
Publicado: (2013)

Peyronie’s penile plication
por: Cordon, Billy H., et al.
Publicado: (2017)

Peyronie’s disease: is it genetic or not?
por: Gabrielsen, J. Scott
Publicado: (2020)

Portrait of La Peyronie
Publicado: (1939)

AB009. Xiaflex as a treatment for Peyronie’s disease
por: McMahon, Chris G.
Publicado: (2015)

Surgical Management for Peyronie's Disease
por: Segal, Robert L., et al.
Publicado: (2013)

US Imaging in Peyronie's Disease
por: Kalokairinou, Kiriaki, et al.
Publicado: (2012)

Peyronie’s disease: current therapy
por: Pendleton, Clay M., et al.
Publicado: (2013)

Commentary on the myths of Peyronie’s disease
por: Wu, Alex K, et al.
Publicado: (2012)

Psychological aspects of Peyronie’s disease
por: Terrier, Jean E., et al.
Publicado: (2016)

Injectable therapy for Peyronie’s disease
por: Chong, Weiliang, et al.
Publicado: (2016)

Grafting techniques for Peyronie’s disease
por: Hatzichristodoulou, Georgios
Publicado: (2016)

Lengthening strategies for Peyronie’s disease
por: Gaffney, Christopher D., et al.
Publicado: (2016)

All about Peyronie's disease
por: Hussein, Ahmed A., et al.
Publicado: (2015)

Biomechanical Simulation of Peyronie's Disease
por: Drlík, Pavel, et al.
Publicado: (2021)

The Natural History of Peyronie's Disease
por: Di Maida, Fabrizio, et al.
Publicado: (2021)

Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
por: Cowie, F. J., et al.
Publicado: (1995)

Pharmacokinetics of doxorubicin co-administered with high-dose verapamil.
por: Gigante, M., et al.
Publicado: (1995)

Penile prosthesis in the surgical treatment of Peyronie's disease
por: Ateia, D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gvkoicb2gmntgcmp2nrikbsfob